Afatinib and Vinorelbine in Tumours Known to Overexpress EGFR and/or HER2
Clinical trial NCT00906698 · COMPLETED
Trial details
- NCT number
- NCT00906698
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-06-01
- Primary completion
- 2013-01-01
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.